Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Addiction
  3. Tobacco smoking and nicotine dependence
  4. Management of tobacco smoking in specific populations
  5. Overview of management of tobacco smoking in specific populations
  • Addiction
    • What is covered in the Addiction guidelines?
    • Overview of substance use and addictive behaviours
    • Tobacco smoking and nicotine dependence
      • Overview of tobacco smoking and nicotine dependence
      • Nicotine replacement therapy for tobacco smoking and nicotine dependence
      • Varenicline for tobacco smoking and nicotine dependence
      • Bupropion for tobacco smoking and nicotine dependence
      • Nortriptyline for tobacco smoking and nicotine dependence
      • Nicotine vaping products for tobacco smoking and nicotine dependence
      • Management of tobacco smoking in specific populations
        • Overview of management of tobacco smoking in specific populations
        • Management of tobacco smoking during pregnancy
        • Management of tobacco smoking during breastfeeding
        • References
    • Alcohol: hazardous, harmful and dependent use
    • Opioids: hazardous, harmful and dependent use
    • Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
    • Cannabis: hazardous, harmful and dependent use
    • Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
    • Hallucinogens: hazardous and harmful use
    • Ketamine: hazardous and harmful use
    • Pregabalin and gabapentin: hazardous, harmful and dependent use
    • Quetiapine and other antipsychotics: hazardous, harmful and dependent use
    • Sedating antihistamines: hazardous, harmful and dependent use
    • Stimulants: hazardous, harmful and dependent use
    • Volatile inhalants: hazardous, harmful and dependent use
    • Addictive behaviours
    • Key resources for substance use and addictive behaviours

Overview of management of tobacco smoking in specific populations

Specific considerations apply in the management of tobacco use in patients who are pregnant or breastfeeding.

For other specific populations see Considerations for specific populations in substance use and addictive behaviours.

  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)